Market revenue in 2023 | USD 1,301.2 million |
Market revenue in 2030 | USD 1,884.8 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 76.02% in 2023. Horizon Databook has segmented the Germany healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The legal aspects of outsourcing are still in their infancy in Germany. Clinical outsourcing transactions, in all their forms, are not subject to any particular regulations. The German Civil Code governs/regulates the outsourcing agreement between two organizations as a contract.
Players in the outsourcing market are gaining competitive and regional knowledge by participating in conventions such as the Annual Outsourcing in Clinical Trials, held in Europe by Arena International. Furthermore, Germany is expected to be a lucrative market for CROs across the globe due to its huge potential in the healthcare sector.
For instance, in December 2023, Finland-based Labquality Corporation acquired Germany-based P.R.I.S.M.A.-CRO GmbH. This marked the entry of the company into the country’s clinical trial services sector.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany healthcare contract research organization market , including forecasts for subscribers. This country databook contains high-level insights into Germany healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account